VBLOC vagal blocking therapy shows promise as a reversible and less extreme alternative to existing bariatric surgeries
In a six-month open label trial involving three medical centers in Australia, Mexico and Norway, the 31 obese participants who received the vagal nerve blocking device, also called VBLOC(TM) vagal blocking therapy, lost an average of nearly 15 percent of their excess weight. A quarter of the participants lost more than 25 percent, and three patients lost more than 30 percent.
Read more: MedicalNewsToday
0 comments:
Post a Comment